Back to Search Start Over

Comparative Evaluation of Cytotoxicity of Zinc Oxide Nanoparticles Mixed With Herbal Extract as an Intracanal Medicament: A Zebrafish Model Study.

Authors :
Manoj A
Ranjan M
Singh S
Ragavendran C
Source :
Cureus [Cureus] 2024 Jul 09; Vol. 16 (7), pp. e64131. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024).
Publication Year :
2024

Abstract

Objective In this study, zebrafish embryos are used to study the cytotoxic effects of a novel intracanal medication (ICM) based on zinc oxide nanoparticles (ZnO NPs) loaded with polyherbal extracts ( Azadirachta indica and Solanum xanthocarpum ). Material and methods In the present study, a green and sustainable method was employed for the synthesis of ZnO NPs mixed with bark and seed extracts of Azadirachta indica and Solanum xanthocarpum to be used as a polyherbal ICM. Formulation of ZnO NPs was confirmed with color change in mixture produced upon dissolving zinc acetate dihydrate in distilled water followed by slow addition of sodium hydroxide solution and herbal extracts. The effects of these green synthesized ZnO NPs were evaluated through a zebrafish embryo toxicity test. Embryos were exposed to different concentrations (25, 50, and 100 µg/mL) of synthesized experimental doses of ZnO NP and compared with the control embryos. Toxicological endpoints, such as the zebrafish embryo's survival rate, hatching rate, and heart rate, were noted and described. Results A concentration-dependent increase in mortality rate and hatching delay followed by declined heart rate was observed in green synthesized ZnO NP-treated embryos. The maximum toxicity was observed with an increase in the concentration of 100 µg/mL of the experimental dose, and at a low concentration of 25 µg/mL, it does not effectively show any developmental alteration in zebrafish embryos. Conclusion A novel polyherbal ICM loaded with ZnO NPs exhibited a dose-dependent effect on the heart rate, hatching, and mortality rate of the embryos. At optimal concentrations, the medication demonstrated minimal developmental malformations and cytotoxic effects, indicating its safety for use. However, increasing concentrations of the medication resulted in severe developmental malformations.<br />Competing Interests: Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: The study was conducted on zebrafish embryos as per national ethical guidelines and was approved by the scientific review board of Saveetha Dental College vide letter number SRB/SDC/ENDO-2204/24/113. Issued protocol number SRB/SDC/ENDO-2204/24/113. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.<br /> (Copyright © 2024, Manoj et al.)

Details

Language :
English
ISSN :
2168-8184
Volume :
16
Issue :
7
Database :
MEDLINE
Journal :
Cureus
Publication Type :
Academic Journal
Accession number :
39119434
Full Text :
https://doi.org/10.7759/cureus.64131